BioPharma Resources

Drugs by condition

Drugs approved for adhd

Brand-name prescription drugs and biologics whose FDA label lists adhd as an approved use. Matched on the label phrases: "attention deficit hyperactivity disorder", "ADHD".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

30

Still marketed, NDA or BLA

Drug classes

2

Novel drugs

4

New molecular entities and new biologics

In development

1

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for adhd.

  • Simtriyo (Centanafadine Hydrochloride) · Otsuka NovelPriority reviewJul 24, 2026
  • Atoncy (Atomoxetine Hydrochloride) · Map77 Mar 20, 2026
  • Arynta (Lisdexamfetamine Dimesylate) · Azurity Jun 16, 2025
  • Onyda Xr (Clonidine Hydrochloride) · Tris Pharma INC May 24, 2024
  • Relexxii (Methylphenidate Hydrochloride) · Osmotica Pharm US Jun 23, 2022

All approved drugs for adhd, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 126 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Central Nervous System Stimulant (6)

  • Xelstrym Dextroamphetamine · Noven Pharms INC · 2022
  • Dyanavel Xr 20 Amphetamine, Amphetamine Aspartate/Dextroamphetamine Sulfate · Tris Pharma INC · 2021
  • Cotempla Xr-Odt Methylphenidate · Neos Theraps INC · 2017
  • Adzenys Xr-Odt Amphetamine · Neos Theraps · 2016
  • Dyanavel Xr Amphetamine, Amphetamine Aspartate/Dextroamphetamine Sulfate · Tris Pharma INC · 2015
  • Daytrana Methylphenidate · Noven Pharms INC · 2006

Class not listed in FDA's data (24)

  • Simtriyo Centanafadine Hydrochloride · Otsuka · 2026
  • Qelbree Viloxazine Hydrochloride · Supernus Pharms · 2021
  • Azstarys Dexmethylphenidate Hydrochloride, Serdexmethylphenidate Chloride · Commave Sub · 2021
  • Vyvanse Lisdexamfetamine Dimesylate · Takeda Pharms USA · 2007
  • Atoncy Atomoxetine Hydrochloride · Map77 · 2026
  • Arynta Lisdexamfetamine Dimesylate · Azurity · 2025
  • Onyda Xr Clonidine Hydrochloride · Tris Pharma INC · 2024
  • Relexxii Methylphenidate Hydrochloride · Osmotica Pharm US · 2022
  • Jornay Pm Methylphenidate Hydrochloride · Ironshore Pharms · 2018
  • Mydayis Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate · Takeda Pharms USA · 2017
  • Vyvanse Lisdexamfetamine Dimesylate · Takeda Pharms USA · 2017
  • Quillichew Er Methylphenidate Hydrochloride · Nextwave Pharms · 2015
  • Aptensio Xr Methylphenidate Hydrochloride · Rhodes Pharms · 2015
  • Quillivant Xr Methylphenidate Hydrochloride · Nextwave · 2012
  • Intuniv Guanfacine Hydrochloride · Takeda Pharms USA · 2009
  • Focalin Xr Dexmethylphenidate Hydrochloride · Sandoz · 2005
  • Methylin Methylphenidate Hydrochloride · Specgx LLC · 2002
  • Ritalin La Methylphenidate Hydrochloride · Sandoz · 2002
  • Focalin Dexmethylphenidate Hydrochloride · Sandoz · 2001
  • Adderall Xr 10 Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate · Takeda Pharms USA · 2001
  • Metadate Cd Methylphenidate Hydrochloride · Lannett · 2001
  • Concerta Methylphenidate Hydrochloride · Janssen Pharms · 2000
  • Dexedrine Spansule Dextroamphetamine Sulfate · Impax Labs INC · 1976
  • Ritalin Methylphenidate Hydrochloride · Sandoz · 1955

Drugs in development for adhd

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • ALKS 7290Phase 21 trial

    Alkermes, Inc. · Attention Deficit Disorder With Hyperactivity (ADHD)

1 discontinued brand-name drugs whose label still names it

More on adhd: recruiting trials · published research

Related in psychiatry: Depression (major depressive disorder) · Schizophrenia · Bipolar disorder · Anxiety disorders · Insomnia · Opioid use disorder · Alcohol dependence · Smoking cessation · PTSD · Postpartum depression

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.